Acne Treatment Market - Forecasts from 2024 to 2029

The acne treatment market is expected to grow at a CAGR of 5.36% from US$11.554 billion in 2022 to US$16.652 billion in 2029.

Treatment for acne includes a variety of methods intended to lessen and control the signs and symptoms of acne, which is a common skin ailment marked by inflammation, blackheads, whiteheads, and pimples. The severity of the acne as well as personal characteristics like skin type and medical history may affect the treatment options. For mild to severe acne, over-the-counter topical therapies with chemicals like salicylic acid, benzoyl peroxide, or retinoids are frequently utilized.

These treatments assist in unclogging pores, decrease inflammation, and stop future outbreaks. A dermatologist may prescribe prescription drugs such as isotretinoin (Accutane), hormone treatment, or oral antibiotics for more severe or chronic acne. In addition, acne lesions can be targeted and skin can be improved using procedures including chemical peels, microdermabrasion, laser therapy, or light-based therapies.

MARKET TRENDS:

Numerous important factors propel the acne treatment market's growth and global expansion. For instance, a major factor driving the market is the increasing incidence of acne, especially in teens and young adults. The rising prevalence of acne is fueled by several causes, including environmental variables, stress, hormone fluctuations, and poor eating habits. These factors also increase the need for efficient treatment options.

Furthermore, there is a growing need for acne treatment products and services due to increased attention to skincare and personal hygiene. Customers are looking for solutions that address their acne issues more since social media platforms and beauty influencers are raising knowledge about skincare regimes and treatment choices.

MARKET DRIVERS:

The growing prevalence of acne globally is anticipated to propel the acne treatment market.

The growing prevalence of acne due to factors such as changing lifestyles, genetics, and untimely routine is a major growth factor in the acne treatment market. According to the National Library of Medicine, Eighty percent of teenagers worldwide suffer from acne in 2023; of them, 20% have moderate-to-severe acne. Furthermore, adult acne is a growing issue that affects 40% of people, according to current estimates. Moreover, according to the American Academy of Dermatology Association (AADA), around 15% of women are affected with acne annually which further widens the acne treatment market size.

The rising adolescent population is predicted to positively impact the market.

The major cause of clogging and acne development is age as teenagers and younger adults are more affected by the acne. The rising global adolescent population causing more acne is indicating the acne treatment market expansion in the coming years. According to UNICEF, there were 1.3 billion adolescents worldwide in April 2022 making up almost 16% of the total world population. Moreover, acne may cause emotional and psychological problems in a person. The growing teenage population along with the severe emotional impact of acne is contemplated to bolster the acne treatment market size.

Technological advancements and related programs might upsurge the market.

The acne treatment market is always changing due to technological breakthroughs that enhance the efficacy, safety, and patient experience of various treatment choices. To maximize the therapeutic benefits of active compounds while minimizing side reactions, novel formulations make use of cutting-edge delivery technologies and components to improve the penetration of active compounds into the skin.

For example, tailored distribution of essential components, like salicylic acid or retinoids, to certain acne-affected skin regions is made possible by microencapsulation and nanotechnology, which improves results and minimizes adverse effects. Furthermore, non-invasive options for treating acne are provided by developments in laser and light-based treatments, which target bacteria, inflammation, and sebum production while encouraging skin regeneration.

MARKET OPPORTUNITIES:

The growing prevalence of acne problems along with the rising adolescent population is rapidly aiding the acne treatment market growth thereby providing an opportunity for market players to enhance the customer experience. Moreover, the problem of acne also happens from bad diet, poor hygiene, and sanitation which are also prevailing in adults. These factors causing the higher prevalence of acne further provide a phenomenal opportunity for market players to enter the acne treatment market.

MARKET RESTRAINTS:

Apart from all the growth factors, a few side effects of acne treatments are expected to limit the acne treatment market growth. The common side effects of topical acne drugs are dryness and irritation which are temporary. The more serious side effects can occur in the case of oral medications such as indigestion, or dizziness caused by antibiotics.

Moreover, acne treatment medications can increase the risk of blood clots and high blood pressure in women taking birth control pills. Serious side effects from oral isotretinoin (a drug for severe acne) are possible, particularly if a woman becomes pregnant while taking it. According to reports, babies born to mothers who used isotretinoin during pregnancy had serious birth defects.

North America is predicted to account for a significant share of the acne treatment market.

North America is expected to hold a significant share of the acne treatment market during the forecast period. The factors attributed to such a share are a huge number of acne-affected people along with higher adoption of acne treatments. For instance, nearly 50 million Americans are affected with acne annually and it is the most common prevailing skin condition in the US as per the AADA. The estimates of the AADA suggest that around 85% of people get affected with at least minor acne and are aged between 12-24 years.

Moreover, the presence of major market players such as Obagi, Skinmedica, and Colorescience further contributes significantly to the acne treatment market growth through product launches and easy accessibility.

Market Developments:

• In October 2023, The U.S. Food and Drug Administration (FDA) approved the New Drug Application for CABTREOTM (clindamycin phosphate, adapalene, and benzoyl peroxide) Topical Gel 1.2%/0.15%/3.1%, indicated for the topical treatment of acne vulgaris in patients twelve years of age and older, according to a statement made by Bausch Health Companies Inc. and its dermatology division, Ortho Dermatologics.
• In July 2023, a part of Crown Laboratories, Inc., Crown Therapeutics announced the release of their PanOxyl 10% Benzoyl Peroxide Acne Treatment Bar. PanOxyl has brought back their well-loved product in response to customer demand, offering a potent remedy for acne sufferers and encouraging smoother, healthier skin.
• In May 2023, the award-winning portfolio of PanOxyl® is being expanded with the introduction of its new PM Balancing Repair Moisturiser and the reformulation of its current AM Oil Control Moisturiser, as announced by Crown Therapeutics, a part of Crown Laboratories.

Segmentation:

By Product

• Retinoids
• Antibiotics
• Isotretinoin
• Others

By Route of Administration

• Oral
• Tropical

By Distribution Channel

• Hospital Pharmacies
• Retail & Online Pharmacies

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others 
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others 
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others 
• Asia Pacific
• China
• Japan
• India
• South Korea
• Taiwan
• Thailand
• Indonesia
• Others